ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding ImageneBio, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 39 | 35 | −4 |
| Shares | 5.36M | 6.23M | +878.7K (+16.4%) |
| Value | $26.8M | $36.8M | +$10.0M (+37.4%) |
New holders (4)
Institutions that held ImageneBio, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Trails Edge Capital Partners, LP | 282,004 | $1.66M | 0.26% |
| Monashee Investment Management LLC | 192,344 | $1.13M | 1.90% |
| Two Sigma Investments, LP | 19,900 | $117.4K | 0.00% |
| Northern Trust Corp | 11,271 | $66.5K | 0.00% |
Sold out (8)
Institutions that held ImageneBio, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 26,663 | $133.3K |
| XTX Topco Ltd | 15,112 | $75.6K |
| HRT Financial LP | 13,909 | $69.0K |
| Jane Street Group, LLC | 13,210 | $66.0K |
| Prelude Capital Management, LLC | 12,990 | $65.0K |
| Royal Bank of Canada | 1,000 | $5.00K |
| Citigroup Inc | 224 | $1.12K |
| Wells Fargo & Company | 41 | $205 |